Humana INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
HUM
Humana INCHumana Inc. reported a significant increase in premiums revenue driven by Medicare membership growth, alongside higher benefits expenses and operating costs for the second quarter of 2026.
NYSE
HUM
Humana INCHumana Inc. reported a 23.5% increase in total revenues for the first quarter of 2026, driven by strong membership growth in its Medicare business, though net income attributable to Humana decreased by 4.7%.
NYSE
HUM
Humana INCHumana Inc. reported a significant 59.4% drop in third-quarter net income to $195 million, primarily due to substantial charges from value creation initiatives and a business divestiture, despite robust revenue growth.
NYSE
HUM
Humana INCHumana Inc. reported a decline in second-quarter net income and diluted EPS, primarily due to valuation adjustments and impairment charges, while six-month results showed growth, as the company navigates membership shifts and an evolving regulatory landscape.
NYSE
HUM
Humana INCHumana Inc. announces a significant increase in net income for Q1 2025, driven by higher Medicare premiums and growth in its CenterWell segment, despite a decline in individual Medicare Advantage membership.
NYSE
HUM
Humana INCHumana's third-quarter 2024 results show a revenue increase but a decrease in net income compared to the same period last year, impacted by higher benefit expenses and other factors.
NYSE
HUM
Humana INCHumana Inc.'s second quarter 2024 results show a decrease in net income compared to the same period last year, primarily due to elevated Medicare Advantage medical costs and adjustments related to minority interest investments.
NYSE
HUM
Humana INCHumana's first quarter 2024 net income decreased to $739 million, down from $1.238 billion in the same period last year, impacted by strategic business exits and increased medical costs.